Comparative Pharmacology
Head-to-head clinical analysis: CHG SCRUB versus HIBISTAT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHG SCRUB versus HIBISTAT.
CHG SCRUB vs HIBISTAT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlorhexidine gluconate disrupts bacterial cell membranes, leading to leakage of intracellular contents and cell death. It also binds to proteins and inhibits bacterial enzymes.
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. Active against susceptible gram-positive bacteria.
Apply 5 mL to wet skin, scrub for 2 minutes, rinse thoroughly. Use undiluted.
1.5 mg/kg intravenously every 6 hours; maximum 120 mg per dose.
None Documented
None Documented
Approximately 2 hours (terminal); prolonged in renal impairment.
Terminal elimination half-life is 2.5–3.5 hours in patients with normal renal function; prolonged in renal impairment, requiring dose adjustment.
Primarily renal (90% unchanged); <5% biliary/fecal.
Approximately 90% of absorbed dose excreted renally as unchanged drug; <5% in feces via biliary elimination.
Category C
Category C
Antiseptic
Antiseptic